{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-115342","form_type":"8-K","ticker":"BNBX","cik":"0000744452","company_name":"BNB PLUS CORP.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.959498+00:00","generated_at":"2026-05-30T04:06:21.583888+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Applied DNA Sciences reduces stockholder quorum to one-third","bullets":["Board adopted Certificate of Amendment to Bylaws effective November 7, 2024.","Quorum for stockholder meetings reduced from majority to one-third (1/3) of issued and outstanding shares.","CEO granted authority to adjourn any stockholder meeting.","No change to fiscal year; only governance adjustments."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-115342","json":"https://secwatch.observer/filing/0001104659-24-115342.json","markdown":"https://secwatch.observer/filing/0001104659-24-115342.md","text":"https://secwatch.observer/filing/0001104659-24-115342.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/744452/000110465924115342/0001104659-24-115342-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/744452/000110465924115342/tm2427797d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:06:21.583888+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"148525f90d83f8958a1794c3751b8328ecf960c1","claim":"BNB PLUS CORP.: Reduced stockholder meeting quorum to one-third of outstanding shares and granted CEO authority to adjourn meetings (effective 2024-11-07).","evidence_excerpt":"On November 7, 2024, the board of directors of Applied DNA Sciences, Inc. (the “Company”) adopted a certificate of amendment (the “Certificate of Amendment”) to its bylaws (the “Bylaws”). Also on November 7, 2024, a duly authorized officer of the Company executed the Certificate of Amendment, which became effective upon execution. Among other things, the Certificate of Amendment amended the Bylaws to: ● Reduce the required quorum for any meeting of stockholders to one-third (1/3) of the issued and outstanding shares entitled to vote at a meeting from a majority of the issued and outstanding shares entitled to vote at a meeting; and ● Grant the Chief Executive Officer of the Company the authority to adjourn any meeting of stockholders of the Company.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/744452/000110465924115342/0001104659-24-115342-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2024-11-07"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}